Shares of Biocorrx Inc. (OTCMKTS:BICX – Get Free Report) crossed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.35 and traded as high as $0.35. Biocorrx shares last traded at $0.35, with a volume of 115 shares trading hands.
Biocorrx Price Performance
The company has a market cap of $8.90 million, a PE ratio of -1.88 and a beta of 0.17. The firm has a 50 day simple moving average of $0.34 and a 200-day simple moving average of $0.35.
Biocorrx (OTCMKTS:BICX – Get Free Report) last released its quarterly earnings results on Friday, May 15th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.03. The firm had revenue of $0.21 million for the quarter, compared to analysts’ expectations of $0.22 million.
Biocorrx Company Profile
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Recommended Stories
- Five stocks we like better than Biocorrx
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Biocorrx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biocorrx and related companies with MarketBeat.com's FREE daily email newsletter.
